Accessibility settings

This paper is in the following e-collection/theme issue:

HIV/AIDS/STI Prevention and Care (1269) Mobile Health (mhealth) (5013) Knowledge Translation and Implementation Science (753) mHealth for Wellness, Behavior Change and Prevention (4194) Text-messaging (SMS, WeChat etc)-Based Interventions (918) mHealth for Treatment Adherence (611) LGBTQ Issues (604)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/60961, first published .
Healthcare professional administering an injection with a syringe and needle to a patient's skin.

Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study

Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study

Authors of this article:

M Cristina Pimenta1 Author Orcid Image ;   Thiago Silva Torres1 Author Orcid Image ;   Brenda Hoagland1 Author Orcid Image ;   Mirian Cohen1 Author Orcid Image ;   Claudio Gruber Mann1 Author Orcid Image ;   Cristina M Jalil1 Author Orcid Image ;   Eduardo Carvalheira1 Author Orcid Image ;   Lucilene Freitas1 Author Orcid Image ;   Nilo Fernandes1 Author Orcid Image ;   Debora Castanheira1 Author Orcid Image ;   Marcos Benedetti1 Author Orcid Image ;   Julio Moreira2 Author Orcid Image ;   Keila Simpson3 Author Orcid Image ;   Roberta Trefiglio1 Author Orcid Image ;   Gabrielle O’Malley4 Author Orcid Image ;   Valdilea G Veloso1 Author Orcid Image ;   Beatriz Grinsztejn1 Author Orcid Image
Article Authors Cited by (9) Tweetations Metrics

Journals

  1. Barnett A, Unternaher J, Dimenstein N, Rakhmanina N. PrEP Implementation with Sexual and Gender Minority Youth: a Review on Barriers and Facilitators. Current Pediatrics Reports 2025;13(1) View
  2. Pimenta C, Mann C, Hoagland B, Carvalheira E, Jalil C, Benedetti M, Fernandes N, Coutinho C, Jalil E, Secco Torres Silva M, Trefiglio R, Farias A, Mourão M, Madruga J, de Lima J, Zonta R, O'Malley G, Veloso V, Grinsztejn B, Torres T. Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB‐Brasil study. Journal of the International AIDS Society 2025;28(S2) View
  3. Zamantakis A, Gomez W, Lukose L, Pachicano A, Kassanits J, Katomski A, Rosenberg-Carlson E, Willging C, Nelson L, Valeriano T, Karris M, Blumenthal J, Rana A, Brewer R, Hamilton A, Kemp C, Humphries D, Benbow N, Kao U, Lee S, Jones J, Schwartz S, Beres L, Rosen J. Barriers to Same-Day Pre-exposure Prophylaxis (PrEP) Implementation in Federally Funded HIV Clinics Within High-Burden Areas of the U.S.: A Coincidence Analysis. AIDS and Behavior 2026;30(2):558 View
  4. Barreto K, Torres T, Freitas L, Hoagland B, Jalil E, Veloso V, Grinsztejn B, Luz P. Pre-exposure prophylaxis use and discontinuation among Brazilian gay, bisexual, and other men who have sex with men: examining the role of internalized homonegativity and discrimination. BMC Infectious Diseases 2025;25(1) View
  5. Qquellon J, Konda K, Elorreaga O, Vega-Ramirez H, Guillén-Díaz-Barriga C, Díaz-Sosa D, Hoagland B, Guanira J, Benedetti M, Pimenta C, Grinsztejn B, Caceres C, Veloso V, Torres T. Profiles of Willingness to Use Pre-Exposure Prophylaxis Modalities and an HIV Vaccine Among Sexual and Gender Minority Individuals in Brazil, Mexico, and Peru: Cross-Sectional Online Survey. JMIR Public Health and Surveillance 2026;12:e75753 View
  6. Quispe-Juli C, Gallardo-Cartagena J, Otero L, Andrade B, Croda J, Cantos V, Mendoza-Ticona A, Valderrama-Beltrán S, Sequera G, Huaman M. Challenges and Opportunities for Improved Tuberculosis and HIV Prevention in South America. Open Forum Infectious Diseases 2026;13(4) View
  7. Raccagni A, Castagna A, Nozza S. Injectable long-acting pre-exposure prophylaxis for HIV prevention: advancements and future directions in pharmacotherapy. Expert Opinion on Pharmacotherapy 2026;27(9):797 View
  8. Torres T, Hoagland B, Coutinho C, Silva M, Moreira R, Leite I, Cunha M, Jalil E, Cardoso S, Trefiglio R, Farias A, Mourão M, Madruga J, de Lima J, Zonta R, O'Malley G, Moreira J, Simpson K, Pines H, Rinehart A, Pilgrim N, Luz P, Benedetti M, Pimenta M, Veloso V, Grinsztejn B. Person-centered choice and mHealth support for same-day delivery of long-acting injectable cabotegravir (ImPrEP CAB Brasil): a prospective, open-label, multicenter, quasi-experimental implementation study. The Lancet Regional Health - Americas 2026;59:101522 View
  9. Concepcion T, Watoyi S, Flaherty B, Abuna F, Akim E, Gómez L, John-Stewart G, Nzove E, Ngumbau N, Mogaka J, Odhiambo B, Wagner A, Kinuthia J, Pintye J. Long-Acting HIV Pre-exposure Prophylaxis Preferences Through Pregnancy and the Postpartum Period Among Women in Kenya: A Latent Transition Analysis. AIDS and Behavior 2026 View